Cookson Peirce & Co’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
BBA
Cookson Peirce & Co's NRIX Position: Q3 2026 in Review
Cookson Peirce & Co sold out of Nurix Therapeutics (NRIX) in Q3 2026, closing a stake of 23,000 shares — an estimated $558K sold.
Cookson Peirce & Co first reported a position in NRIX in Q2 2026 and held it in 1 quarter. The position peaked at $558K in Q2 2026. 234 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.
- Cookson Peirce & Co reported no remaining Nurix Therapeutics position as of Q3 2026 after selling out during the quarter.
- Cookson Peirce & Co sold 23,000 Nurix Therapeutics shares in Q3 2026, an estimated $558K.
- Cookson Peirce & Co first reported a position in Nurix Therapeutics in Q2 2026 and held it in 1 quarter.
- Cookson Peirce & Co's Nurix Therapeutics position peaked at $558K in Q2 2026.
- 234 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.
Based on Cookson Peirce & Co's 13F filing for Q3 2026, filed 30 Oct 2026.